Evidence map›Paper›PMID 39698004›Full record

ArticleClinical case reports2024

A Chinese Girl With LIG4 Syndrome and Hematopoietic Stem Cell Transplantation: A Rare Case Report and Review of the Literature.

Chenjia Jiang, Wenyang Wang, Yazhou Li, Xiwang Liu, Zhirui Zhu

Abstract read
In one paragraph

Article in Clinical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chenjia JiangDepartment of Anesthesiology Children's Hospital, Zhejiang University School of Medicine Hangzhou China.
Wenyang WangDepartment of Anesthesiology Children's Hospital, Zhejiang University School of Medicine Hangzhou China.
Yazhou LiDepartment of Clinical Laboratory Huadong Hospital, Fudan University Shanghai China.
Xiwang LiuDepartment of Cardiac Surgery Children's Hospital, Zhejiang University School of Medicine Hangzhou China.
Zhirui ZhuDepartment of Anesthesiology Children's Hospital, Zhejiang University School of Medicine Hangzhou China.ORCID https://orcid.org/0009-0005-1125-4422

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LIG4 syndrome is an exceptionally rare primary immune deficiency. It is an autosomal recessive genetic disease, falling within the spectrum of genetic disorders characterized by impaired DNA damage response mechanisms. Common clinical characteristics encompass microcephaly, growth retardation, developmental delays, facial deformities, variable immune deficiencies, pancytopenia, heightened susceptibility to malignant tumors, and significant clinical and cellular radiosensitivity. Hematopoietic stem cell transplantation (HSCT) is a curative treatment for LIG4 syndrome and may mitigate the long-term risk of developing lymphoid malignancies by improving tumor surveillance.

Indexed as

combined immunodeficiencyDNA ligase 4 syndromehematopoietic stem cell transplantationpediatrics

Identifiers

PMID39698004
PMCPMC11652113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.